Skip to main content
Fig. 2 | BMC Biology

Fig. 2

From: Transcription dosage compensation does not occur in Down syndrome

Fig. 2

Fold change distributions of RNA-seq and GRO-seq datasets. A Pipeline of differential analysis. Variations at any step have the potential to increase or decrease fold change calculations for chromosome 21 genes (see also Additional File 1: Figs. S11, S15, S16). B Naive differential analysis of simulated T21 and D21 datasets using the similar dispersion parameters found in real data (asymptotic dispersion = 0.03, extra-Poisson noise = 3.5, see Additional File 1: Fig. S11). For chromosome 21 genes (which were simulated at 1.5×), the median fold change is 1.40. C Effects of shifting parameters of simulated datasets. Simulated datasets with varying numbers of replicates (asymptotic dispersion = .01, extra-Poisson noise = 1). D Simulated datasets with varying levels of depth (asymptotic dispersion = .01, extra-Poisson noise = 1). E Violin plots showing fold changes of simulated datasets when dispersion parameters are low (asymptotic dispersion = .01, extra-Poisson noise = 1). The orange line is the Median Fold Change (MFC). F Violin plots showing fold changes of simulated datasets when dispersion parameters are high (asymptotic dispersion = .05, extra-Poisson noise = 30). The orange line is the Mean Fold Change (MFC). G Simulated data violin plots showing fold changes after applying adjustments for each step in the pipeline. Results are consistent with no dosage compensation in T21 datasets in the simulated data

Back to article page